UBS Group AG - HOTH THERAPEUTICS INC ownership

HOTH THERAPEUTICS INC's ticker is HOTH and the CUSIP is 44148G105. A total of 21 filers reported holding HOTH THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of HOTH THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,000
-50.0%
4,042
-31.4%
0.00%
Q2 2022$2,000
-71.4%
5,891
-43.7%
0.00%
Q1 2022$7,000
+600.0%
10,458
+975.9%
0.00%
Q3 2021$1,000
-90.9%
972
-82.0%
0.00%
Q1 2021$11,0000.0%5,398
+16.1%
0.00%
Q4 2020$11,000
+450.0%
4,650
+666.1%
0.00%
Q2 2020$2,0000.0%607
+17.6%
0.00%
Q1 2020$2,000
-84.6%
516
-74.8%
0.00%
Q4 2019$13,000
+1200.0%
2,047
+571.1%
0.00%
Q3 2019$1,000
-92.3%
305
-86.7%
0.00%
Q2 2019$13,000
+1200.0%
2,285
+1003.9%
0.00%
Q1 2019$1,0002070.00%
Other shareholders
HOTH THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Game Plan Financial Advisors, LLC 24,500$17,0000.01%
Signet Investment Advisory Group, Inc. 10,000$7,0000.00%
OSAIC HOLDINGS, INC. 101$453,0000.00%
Virtu Financial LLC 24,984$17,0000.00%
VANGUARD GROUP INC 764,646$529,0000.00%
UBS Group AG 10,458$7,0000.00%
WELLS FARGO & COMPANY/MN 136$00.00%
NORTHERN TRUST CORP 58,424$40,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 120,361$83,0000.00%
View complete list of HOTH THERAPEUTICS INC shareholders